4D Molecular Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
4D Molecular Therapeutics Inc
CIK #0001650648
EDGAR Form CIK 2011 - 2026
10-K [0001650648]
10-Q [0001650648]
3 [0001650648]
4 [0001650648]
8-K [0001650648]
D [0001650648]
SC 13G [0001650648]
Form 13D/13G Filer Form 13D/13G Subject Filed
State Street Corp 4D Molecular Therapeutics Inc [2026-05-12]
Janus Henderson Group PLC 4D Molecular Therapeutics Inc [2026-02-17]
Novo Holdings A/S 4D Molecular Therapeutics Inc [2025-10-20]
Goldman Sachs Group Inc 4D Molecular Therapeutics Inc [2024-11-06]
Vanguard Group Inc 4D Molecular Therapeutics Inc [2024-11-04]
RA Capital Management LP 4D Molecular Therapeutics Inc [2023-06-05]
Venrock Healthcare Capital Partners III LP 4D Molecular Therapeutics Inc [2023-05-15]
Janus Henderson Group PLC 4D Molecular Therapeutics Inc [2022-02-11]
BlackRock Inc 4D Molecular Therapeutics Inc [2022-02-04]
Deep Track Capital LP 4D Molecular Therapeutics Inc [2021-11-04]
View All
Form 3/4/5 Subject 2011 - 2026
4D Molecular Therapeutics Inc
Bizily Scott
Kirn David
Sblendorio Glenn
Theuer Charles
Miller-Rich Nancy
Gray Susannah
Milligan John F
Chacko Jacob
Tomasello Shawn
Simms Christopher Paul
Gupta Ashoo
Humer Kristian
Mehra Uneek
Kamal Fariborz
Kim Robert Young
Shah Rajeev M
RA Capital Healthcare Fund LP
RA Capital Management LP
Kolchinsky Peter
BVF Inc/IL
Biotechnology Value Trading Fund OS LP
BVF Partners L P/IL
Lampert Mark N
BVF GP Holdings LLC
BVF II GP LLC
BVF Partners OS Ltd
Biotechnology Value Fund L P
Biotechnology Value Fund II LP
BVF I GP LLC
Viking Global Opportunities GP LLC
Viking Global Investors LP
Viking Global Opportunities Illiquid Investments Sub-Master
Viking Global Opportunities Parent GP LLC
Viking Global Opportunities Portfolio GP LLC
Halvorsen Ole Andreas
Shabet Rose Sharon
Ott David C
Kasahara Noriyuki
Moretti August J
Fishman Robert S
Zimmermann Carolyne
Schaffer David
Yao Tony DUNG Ling
Burkoth William T
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
4D Molecular Therapeutics Inc FDMT
Stock Option (Right to Buy) · derivative
2026-03-25 Grant 219,000 $0.00
4D Molecular Therapeutics Inc FDMT
Stock Option (Right to Buy) · derivative
2026-03-25 Grant 750,000 $0.00
4D Molecular Therapeutics Inc FDMT
Stock Option (Right to Buy) · derivative
2026-03-25 Grant 217,000 $0.00
4D Molecular Therapeutics Inc FDMT
Common Stock
2026-03-20 Option exercise 865
4D Molecular Therapeutics Inc FDMT
Restricted Stock Units · derivative
2026-03-20 Option exercise 865 $0.00
4D Molecular Therapeutics Inc FDMT
Restricted Stock Units · derivative
2026-03-20 Option exercise 221 $0.00
4D Molecular Therapeutics Inc FDMT
Common Stock
2026-03-20 Option exercise 221
4D Molecular Therapeutics Inc FDMT
Common Stock
2026-03-20 Sell 80 $8.61 689
4D Molecular Therapeutics Inc FDMT
Common Stock
2026-03-20 Sell 310 $8.61 2,669
4D Molecular Therapeutics Inc FDMT
Stock Option (Right to Buy) · derivative
2026-01-05 Grant 45,000 $0.00
4D Molecular Therapeutics Inc FDMT
Restricted Stock Units · derivative
2025-12-20 Option exercise 220 $0.00
4D Molecular Therapeutics Inc FDMT
Common Stock
2025-12-20 Sell 310 $8.68 2,691
4D Molecular Therapeutics Inc FDMT
Common Stock
2025-12-20 Option exercise 220
4D Molecular Therapeutics Inc FDMT
Common Stock
2025-12-20 Sell 79 $8.68 686
4D Molecular Therapeutics Inc FDMT
Common Stock
2025-12-20 Option exercise 866
4D Molecular Therapeutics Inc FDMT
Restricted Stock Units · derivative
2025-12-20 Option exercise 866 $0.00
4D Molecular Therapeutics Inc FDMT
Common Stock
2025-12-16 Option exercise 1,635 $4.14 6,769
4D Molecular Therapeutics Inc FDMT
Stock Option (Right to Buy) · derivative
2025-12-16 Option exercise 1,635 $0.00
4D Molecular Therapeutics Inc FDMT
Common Stock
2025-12-16 Sell 1,635 $10.90 17,822
4D Molecular Therapeutics Inc FDMT
Common Stock
2025-12-12 Option exercise 9,333 $1.14 10,640
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com